Skip to main content
Binex Co., Ltd. logo

Binex Co., Ltd. — Investor Relations & Filings

Ticker · 053030 ISIN · KR7053030003 KO Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2020-11-12 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 053030

About Binex Co., Ltd.

http://www.binex.co.kr/

Binex Co., Ltd. is a biopharmaceutical company engaged in two main sectors: synthetic pharmaceuticals and biologics contract services. The pharmaceutical division manufactures and distributes a portfolio of products, including gastrointestinal tract regulators, antispasmodics, and anti-cancer drugs. As a Contract Development and Manufacturing Organization (CDMO), the company provides comprehensive services for biologics, specializing in cell line development, process development, and analytical method development. Its quality management systems are recognized by major international regulatory authorities such as the FDA, EMA, and PMDA, establishing it as a key partner in biopharmaceutical development and manufacturing.

Recent filings

Filing Released Lang Actions
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company Binex (주)바이넥스, covering the period from January 1, 2020, to September 30, 2020. It contains detailed financial information, company history, management changes, and capital structure updates, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-11-12 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as the '5% rule' report). It details the acquisition of convertible bonds by Kwangdong Pharmaceutical (광동제약) in Binex (바이넥스), resulting in a change in shareholding percentage. This falls under the category of Major Shareholding Notification.
2020-10-07 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically, convertible bonds). It details the issuance method, amount, and payment date. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2020-10-06 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the 'Result of Securities Issuance' (증권 발행결과) for a private exchangeable bond (사모 교환사채). It details the issuance amount, payment date, and the nature of the securities. This falls under the category of company financing and capital structure updates, which is best classified as CAP (Capital/Financing Update).
2020-10-06 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '자기주식처분결과보고서' (Report on the Results of Disposal of Treasury Shares) filed with the Financial Supervisory Service (FSS) in South Korea. It details the disposal of treasury shares in connection with the issuance of exchangeable bonds. This type of filing is a specific regulatory disclosure regarding the company's own share transactions, which falls under the 'Transaction in Own Shares' category.
2020-10-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service and the Korea Exchange. It details specific share transactions (disposals) made by an executive (Lee Hyung-il) of Binex Co., Ltd. This type of filing is a standard regulatory disclosure for insider trading/director dealings.
2020-09-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.